Development and biodistribution of 188Re-SSS lipiodol following injection into the hepatic artery of healthy pigs

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 4, 2004, Pages 542-546

  Garin, E ^a   Noiret, N ^b   Malbert, C ^c   Lepareur, N ^b   Roucoux, A ^b   Caulet Maugendre, S ^d   Moisan, A ^a   Lecloirec, J ^a   Herry, J Y ^a   Bourguet, P ^a  

^a CENTRE EUGÈNE MARQUIS   (France)

^b CNRS   (France)

^c CEMAGREF   (France)

^d PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Animal; Hepatocellular carcinoma; Liver; Metabolic radiotherapy

Indexed keywords

IODINATED POPPYSEED OIL; RHENIUM 188; SSS LIPIODOL RE 188; UNCLASSIFIED DRUG; ORGANOMETALLIC COMPOUND; RADIOPHARMACEUTICAL AGENT; RHENIUM SSS LIPIODOL; RHENIUM-SSS-LIPIODOL;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG PURITY; HEPATIC ARTERY; INTESTINE CELL; LIVER CELL CARCINOMA; LIVER METABOLISM; LUNG PARENCHYMA; NONHUMAN; REPRODUCIBILITY; SWINE; URINALYSIS; ANIMAL; ANTIBODY SPECIFICITY; DRUG COMBINATION; EVALUATION; FEASIBILITY STUDY; INTRASPINAL DRUG ADMINISTRATION; ISOTOPE LABELING; LIVER; LIVER TUMOR; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; SCINTISCANNING; SYNTHESIS; TISSUE DISTRIBUTION; VASCULARIZATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; DRUG COMBINATIONS; FEASIBILITY STUDIES; HEPATIC ARTERY; INJECTIONS, SPINAL; IODIZED OIL; ISOTOPE LABELING; LIVER; LIVER NEOPLASMS; METABOLIC CLEARANCE RATE; ORGAN SPECIFICITY; ORGANOMETALLIC COMPOUNDS; RADIOPHARMACEUTICALS; SWINE; TISSUE DISTRIBUTION;

EID: 11144353732     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1402-z     Document Type: Article

References (15)

1. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999; 19:271-285.
2. Lau WY. Management of hepatocellular carcinoma. J R Coll Surg Edinb 2002; 47:389-399.
3. Garin E, Bourguet P. Radiolipiodol of liver tumors. In: Ell PJ, Gambhir SS, eds. Nuclear medicine in clinical diagnosis and treatment, 3rd edn. Edinburgh: Elsevier Science; 2003:in press.
4. 131I-labeled iodized oil in the treatment of hepatocellular carcinoma. Hepatology 1997; 26:1156-1161.
5. Raoul JL, Guyader D, Bretagne JF, Duvauferrier R, Bourguet P, Bekhechi D, Deugnier Y, Gosselin M. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med 1994; 35:1782-1787.
6. Lau WY, Leung TWT, Ho SKW, Chan M, Machin D, Lau J, Chan ATC, Yeo W, Mok TSK, Yu SCH, Leung NWY, Johnson PJ. Adjuvant intra-arterial iodine-131-labelled lipiodol for respectable hepatocellular carcinoma: a prospective randomized trial. Lancet 1999; 353:797-801.
7. 188Re-TDD, for the treatment of liver cancer. Nucl Med Biol 2001; 28:197-204.
8. 188Re-labelled long chain alkyl diaminedithiol for therapy of liver cancer. Nucl Med Commun 2002; 23:237-242.
9. Sundram FX, Jeong JM, Zanzonico P, Bernal P, Chau T, Onkhuudai P, Divgi C, Knapp FF (Russ) Jr. Trans-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma. An IAEA sponsored multi-centre phase 1 study. World J Nucl Med 2002; 1:5-11.
10. Mévellec F, Tisato F, Refosco F, Roucoux A, Noiret N, Patin H, Bandoli G. Synthesis and characterization of the "sulfur-rich" bis(perthiobenzoato)(dithiobenzoato)technetium(III) heterocomplex. Inorg Chem 2002; 41:589-601.
11. 99mTc-labelled lipiodol: biodistribution following injection into hepatic artery of healthy pig. Nucl Med Commun 2003:in press.
12. Hambue AS, Dobbeleir AA, Vervaet AM, Knapp FF Jr. Image quality with rhenium-188 and technetium-99m: comparative planar and SPECT evaluation in a phantom study and implications for dosimetry. World J Nucl Med 2002; 1:12-20.
13. Raoul JL, Bourguet P, Bretagne JF, Duvauferrier R, Coornaert S, Darnault P, Ramée A, Herry JY, Gastard J. Hepatic artery injection of I-131-labeled lipiodol. Part 1. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases. Radiology 1988; 168:541-545.
14. 188Re-lipiodol for locoregional treatment of hepatocellular carcinoma: a phase I study. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S219.
15. Kan Z, Ivancev K, Hägerstrand I, Chuang VP, Lunderquist A. In vivo microscopy of the liver after injection of lipiodol into the hepatic artery and portal vein in the rat. Acta Radiol 1989; 30:419-425.